Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00882544 · ClinicalTrials.gov registry record

Prospective Pediatric Pyeloplasty Robotic Surgical Database

A clinical trial of Hydronephrosis, sponsored by Connecticut Children's Medical Center.

Completed
Registry status
78
Enrollment target
1
Study location

NCT00882544: Completed study of Hydronephrosis, sponsored by Connecticut Children's Medical Center.

NCT00882544 is a study of Hydronephrosis that has completed, run by Connecticut Children's Medical Center. The registered enrollment target is 78 participants, below the 818-participant average among 3 other Hydronephrosis trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00882544, a study of Hydronephrosis, has completed, sponsored by Connecticut Children's Medical Center.

COMPLETED
Registry status
78 participants
Enrollment target
1
Study location

Study Summary

Performance and outcomes measure are, at this time, relatively unknown for robotic pyeloplasty procedures. The purpose of this study is to provide a clearer understanding of the urology department's robotic pyeloplasty quality and outcomes measures. This will be accomplished by prospectively collecting data for these procedures would ensure that measures are consistently collected in accordance with a defined protocol, allowing for more valuable quality and clinical research analysis. Hypothesis will be defined before data analysis is performed. Amendments specifying future hypothesis will be submitted the IRB at the appropriate time.

Conditions Studied

Study Locations (1)

Connecticut

  • Connecticut Children's Medical Center - Hartford

Trial Details

FieldValue
Enrollment Target 78 participants
Start Date 2009-03
Est. Completion 2016-10

What the finished NCT00882544 record still lists

NCT00882544 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 78 participants, a relatively small participant target, below the 818-participant average among 3 other Hydronephrosis trials with a reported enrollment target (90% lower).

The record links to 1 condition, with Hydronephrosis appearing as the primary indexed condition, and to 0 interventions.

NCT00882544 reports a single indexed study location in Connecticut.

Frequently Asked Questions

What is clinical trial NCT00882544 about?

NCT00882544 is a clinical study titled "Prospective Pediatric Pyeloplasty Robotic Surgical Database". Performance and outcomes measure are, at this time, relatively unknown for robotic pyeloplasty procedures. The purpose of this study is to provide a clearer understanding of the urology department's robotic pyeloplasty quality and outcomes measures. This will be accomplished by prospectively collect...

What is the current status of trial NCT00882544?

This trial is currently completed. The enrollment target is 78 participants. The study started on 2009-03. Estimated completion is 2016-10.

What conditions does trial NCT00882544 study?

This clinical trial studies the following conditions: Hydronephrosis.

Who is sponsoring clinical trial NCT00882544?

This trial is sponsored by Connecticut Children's Medical Center, which has 55 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00882544 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hydronephrosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02397668 · 78 participants · NA

    CorMatrix Cor TRICUSPID ECM Valve Replacement Study

  • NCT03321656 · 78 participants · Phase 2

    Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile

  • NCT03687814 · 78 participants · NA

    Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation

  • NCT04018872 · 78 participants · Phase 2

    Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00882544, the US trial registry maintained by the National Library of Medicine. NCT00882544 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.